The dispute centers on a letter sent by YZi Labs to the CEA board, which argued that the failure to set a date for the 2025 annual meeting disenfranchises investors. The shareholder warned that the delay could trigger a deficiency notice from Nasdaq, potentially jeopardizing the company’s standing on the exchange.

Regulatory Standing and Shareholder Concerns

CEA Industries countered the claims, stating its current status meets all regulatory requirements. Management noted that under Nasdaq rules, companies failing to hold an annual meeting by the close of the fiscal year are typically permitted to submit a formal plan to regain compliance before any delisting procedures begin.

While the shareholder remains concerned about transparency and governance, the company maintains that its administrative timeline is within acceptable bounds. The exchange of public statements highlights growing tension between the board and activist-leaning investors over corporate oversight and regulatory adherence.